MoneyTree Report Shows VC Investment in Biotech Startups Slips 20 Percent in Q4
January 26, 2009
MoneyTree Report Shows VC Investment in Biotech Startups Slips 20 Percent in Q4
The declines also showed that eight of 23 states with biotech VC activity in the final three months of 2008 recorded decreased funding over the year-ago period, with the steepest slides recorded in established biocluster states.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.